3HVGHES E, SPRY P, DIAMOND J. 24-hour monitoring of intraocular pressure in glaucoma management. A retrospective review [J]. J of Glaucoma,2003, (12) : 232-236. 被引量：1
4Michaud JE,Friren B.Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:235-243. 被引量：1
5Netland PA,Landry T,Sullivan EK,et al.Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:472-484. 被引量：1
6Richard KP.A comparison of latanoprost,bimatoprost and travoprost in patients with elevated intraocular pressure:a 12-week,randomized,masked-evaluator multicenter study.Am J Ophthalmol,2004,137:387-388. 被引量：1
8Leske MC,Heijl A,Hussein M,et al.Factors for glaucoma progression and the effect of treatment:the early manifest glaucoma trial.Arch Ophthalmol,2003,121:48-56. 被引量：1
9Leskea MC,Heijl A,Hyman L,et al.Factors for progression and glaucoma treatment:the early manifest glaucoma trial.Curr Opin Ophthalmol,2004,15:102-106. 被引量：1
10AGIS Investigators.The advanced glaucoma intervention study (AGIS):7.the relationship between control of intraocular pressure and visual field deterioration.Am J Ophthalmol,2000,130:429-440. 被引量：1
